MedTrace Logo

Erythrocytapheresis for Chronic Mountain Sickness

NCT04557995 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-04-02

No results posted yet for this study

Summary

The study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness

Conditions

  • Chronic Mountain Sickness

Interventions

PROCEDURE

Erythropheresis

The procedure involves the extracorporeal removal of a specific volume of erythrocytes using an automated cell separator. Following the centrifugal separation of whole blood, the patient's plasma and other cellular components are concurrently re-infused, often supplemented with a replacement fluid (such as saline) to maintain isovolemia.

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Ye Fan · Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-21
Primary Completion
2029-01-01
Completion
2029-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04557995 on ClinicalTrials.gov